Clinical Trial Update: Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes [Phase 4]

View source ↗

Summary

This clinical trial update reports results from a Phase 4 study investigating the effect of pioglitazone on TIMP-3 and TACE in individuals with Type 2 diabetes.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2014-11-13